CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily.

Department of Cell Biology and Anatomy, University of Miami School of Medicine (G.R.G.), Miami, Florida 33136; Department of Molecular Genetics, University of Illinois College of Medicine (L.F.L.), Chicago, Illinois 60607; Laboratoire d’Oncologie Virale et Moleculaire, UFR de Biochimie, Universite Paris 7 (B.P.), 75005 Paris, France; and INSERM U-515, Hopital Saint Antoine (B.P.), Paris 75012, France

[1]  T. Straser.  [Clearance]. , 2020, Medicinski glasnik.

[2]  J. Zeitlhofer,et al.  Clinical significance of autoimmune thyroid disease in myasthenia gravis. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[3]  H. Hedeland,et al.  On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. , 2009, Acta medica Scandinavica.

[4]  J. Hodges,et al.  Triple H syndrome: a novel autoimmune endocrinopathy characterized by dysfunction of the hippocampus, hair follicle, and hypothalamic-pituitary adrenal axis. , 2000, The Journal of clinical endocrinology and metabolism.

[5]  L. del Viscovo,et al.  Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  J. Flier,et al.  Leptin, nutrition, and reproduction: timing is everything. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  Gary R. Grotendorst,et al.  Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP , 1999 .

[8]  S. Mariotti,et al.  Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: Results of a community-based study in northwestern Sardinia , 1999, Journal of endocrinological investigation.

[9]  K. Polonsky,et al.  Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  L. Lau,et al.  Activation-dependent Adhesion of Human Platelets to Cyr61 and Fisp12/Mouse Connective Tissue Growth Factor Is Mediated through Integrin αIIbβ3 * , 1999, The Journal of Biological Chemistry.

[11]  Y. Itoyama,et al.  Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies , 1999, Journal of Neurology.

[12]  L. Lau,et al.  The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.

[13]  D. Brigstock.  The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .

[14]  L. Lau,et al.  Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.

[15]  E. Wilson,et al.  Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. , 1999, The Journal of clinical endocrinology and metabolism.

[16]  B He,et al.  The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Steinhoff,et al.  diagnosis of Creutzfeldt-Jakob disease , 1998 .

[18]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[19]  D. Botstein,et al.  WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Coffey,et al.  Identification of rCop-1, a New Member of the CCN Protein Family, as a Negative Regulator for Cell Transformation , 1998, Molecular and Cellular Biology.

[21]  S. Mohan,et al.  Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. , 1998, The Journal of clinical endocrinology and metabolism.

[22]  Gary R. Grotendorst,et al.  Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  R. Simó,et al.  Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours , 1998, Clinical endocrinology.

[24]  T. Remer,et al.  Short-term impact of a lactovegetarian diet on adrenocortical activity and adrenal androgens. , 1998, The Journal of clinical endocrinology and metabolism.

[25]  T. V. Kolesnikova,et al.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Yokota,et al.  Expression of the Elm1 Gene, a Novel Gene of the CCN (Connective Tissue Growth Factor, Cyr61/Cef10, and Neuroblastoma Overexpressed Gene) Family, Suppresses In Vivo Tumor Growth and Metastasis of K-1735 Murine Melanoma Cells , 1998, The Journal of experimental medicine.

[27]  B. Ambrosi,et al.  Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. , 1998, European journal of endocrinology.

[28]  L. Lau,et al.  Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin αvβ3 * , 1998, The Journal of Biological Chemistry.

[29]  R. Skoda,et al.  Leptin Receptor Immunoreactivity in Chemically Defined Target Neurons of the Hypothalamus , 1998, The Journal of Neuroscience.

[30]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[31]  T. V. Kolesnikova,et al.  Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. , 1997, Developmental biology.

[32]  E. Wilson,et al.  Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Gary R. Grotendorst.  Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .

[34]  M. Kimura,et al.  Role of leptin in hypothalamic-pituitary function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Morris,et al.  Effect of age on blood acid-base composition in adult humans: role of age-related renal functional decline. , 1996, The American journal of physiology.

[36]  S. Nagalla,et al.  Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7 , 1996, The Journal of Biological Chemistry.

[37]  M. Fassnacht,et al.  Adrenal incidentalomas: a manifestation of the metabolic syndrome? , 1996, Endocrine research.

[38]  R. Nachtigall,et al.  The Use of Intravenous Immunoglobulin in Recurrent Pregnancy Loss Associated With Combined Alloimmune and Autoimmune Abnormalities , 1996, American journal of reproductive immunology.

[39]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[40]  M. Schlumberger,et al.  Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. , 1996, European journal of cancer.

[41]  L. Lau,et al.  Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion , 1996, Molecular and cellular biology.

[42]  M. Westphal,et al.  Differential expression of novH and CTGF in human glioma cell lines , 1996, Clinical molecular pathology.

[43]  S. Aizawa,et al.  A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. , 1996, Oncogene.

[44]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[45]  T. Remer,et al.  Potential renal acid load of foods and its influence on urine pH. , 1995, Journal of the American Dietetic Association.

[46]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[47]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[48]  M. Krempf,et al.  Comparative study of the acute effects of resistant starch and dietary fibers on metabolic indexes in men. , 1994, The American journal of clinical nutrition.

[49]  P. Ladenson,et al.  Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[50]  P. Bork.  The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.

[51]  H. Adlercreutz,et al.  Serum sex hormone-binding globulin, cardiovascular risk factors, and adrenal cortisol responses to dexamethasone and corticotropin. , 1993, Metabolism: clinical and experimental.

[52]  Gary R. Grotendorst,et al.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.

[53]  D. Johnston,et al.  The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. , 1992, The Journal of clinical endocrinology and metabolism.

[54]  V. Joliot,et al.  Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.

[55]  Gary R. Grotendorst,et al.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.

[56]  L. Lau,et al.  Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[57]  M. Kaplan,et al.  Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. , 1990, Endocrinology and metabolism clinics of North America.

[58]  E. Kaplan,et al.  Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.

[59]  L. Lau,et al.  Expression of cyr61, a growth factor-inducible immediate-early gene , 1990, Molecular and cellular biology.

[60]  R. Baxter,et al.  On the nomenclature of the IGF binding proteins. , 1989, Acta endocrinologica.

[61]  D. Ross,et al.  Incidentally discovered adrenal masses. , 1989, American journal of surgery.

[62]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[63]  T. Panzarella,et al.  Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. , 1988, International journal of radiation oncology, biology, physics.

[64]  A. Goolden.  THE INDICATIONS FOR ABLATING NORMAL THYROID TISSUE WITH 131I IN DIFFERENTIATED THYROID CANCER , 1985, Clinical endocrinology.

[65]  B. Caillou,et al.  Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma , 1985, Cancer.

[66]  J. Sisson.  Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  D. Linch,et al.  CUSHING'S SYNDROME—KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSIS , 1982, The Lancet.

[68]  R. Urbanic,et al.  Cushing's Disease—18 Years' Experience , 1981, Medicine.

[69]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[70]  G. Reaven,et al.  Insulin and Glucose Responses to Identical Oral Glucose Tolerance Tests Performed Forty-eight Hours Apart , 1974, Diabetes.

[71]  K. Kosaka,et al.  Reproducibility of the Oral Glucose Tolerance Test and the Rice-Meal Test in Mild Diabetics , 1966, Diabetes.

[72]  G. F. Fisher,et al.  Reproducibility of the Oral Glucose Tolerance Test , 1965, Diabetes.

[73]  H. Blumenthal,et al.  Small adenomas of the adrenal cortex in hypertension and diabetes. , 1945, Archives of internal medicine.

[74]  A. Araujo,et al.  Diet and sex hormone-binding globulin. , 2000, The Journal of clinical endocrinology and metabolism.

[75]  S. Chanock,et al.  Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. , 2000, The Journal of clinical endocrinology and metabolism.

[76]  R.,et al.  Androgens and the Postmenopausal Woman , 2000 .

[77]  S. Plymate,et al.  The insulin-like growth factor-binding protein superfamily. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[78]  E. Baudin,et al.  Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? , 2000, The Journal of clinical endocrinology and metabolism.

[79]  R. Tresserras,et al.  Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. , 1999, Diabetes research and clinical practice.

[80]  M. Schlumberger,et al.  THERAPEUTIC CONTROVERSY The Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer , 1998 .

[81]  T. V. Kolesnikova,et al.  CYR 61 , a product of a growth factor-inducible immediate early gene , promotes angiogenesis and tumor growth , 1998 .

[82]  R. Steiner,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society The Stimulatory Effect of Leptin on the Neuroendocrine Reproductive Axis of the Monkey* , 2022 .

[83]  高野 加寿恵,et al.  Molecular mechanisms to regulate the activities of insulin-like growth factors : proceedings of the 4th International Symposium on Insulin-like Growth Factors, at Tokyo International Forum, Tokyo, Japan, 21-24 October 1997 , 1998 .

[84]  R. Rosenfeld,et al.  Editorial: The Blind Men and the Elephant-A Parable for the Study of Insulin-Like Growth Factor Binding Proteins. , 1998, Endocrinology.

[85]  Gary R. Grotendorst,et al.  Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[86]  Drop Sl.  Report on the nomenclature of the IGF binding proteins. , 1992, The Journal of clinical endocrinology and metabolism.

[87]  R. Baxter,et al.  Report on the nomenclature of the IGF binding proteins. , 1992, Endocrinology.

[88]  E. Mazzaferri.  Treating differentiated thyroid carcinoma: where do we draw the line? , 1991, Mayo Clinic proceedings.

[89]  J. Roberts,et al.  Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. , 1990, Neuron.

[90]  S. Reiser.  Metabolic effects of dietary pectins related to human health. , 1987 .

[91]  M. O. Dayhoff,et al.  Atlas of protein sequence and structure , 1965 .